CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,631,464
- in 9 filings, $6.6M under 10b5-1 plans
Net −$6,631,464. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-04 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,292 | $68.57 | $706K | 383,868 |
| 2026-05-14 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −679 | $73.06 | $50K | 405,891 |
| 2026-05-14 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,221 | $73.08 | $528K | 398,670 |
| 2026-05-14 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,100 | $73.08 | $153K | 396,570 |
| 2026-05-14 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,572 | $72.46 | $186K | 393,998 |
| 2026-05-13 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +12,500 | 406,570 | ||
| 2026-04-21 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,850 | $70.91 | $202K | 394,070 |
| 2026-03-12 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,662 | $64.08 | $171K | 396,920 |
| 2026-03-11 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +12,500 | 399,582 | ||
| 2026-02-18 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,371 | $69.36 | $511K | 387,082 |
| 2026-01-08 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,514 | $76.45 | $192K | 394,453 |
| 2026-01-07 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,016 | $77.48 | $234K | 396,967 |
| 2026-01-06 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,149 | $76.95 | $396K | 399,983 |
| 2026-01-02 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award | +63,000 | 405,132 | ||
| 2026-01-02 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +157,500 | 157,500 | ||
| 2025-12-30 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,089 | $76.64 | $620K | 341,875 |
| 2025-12-02 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,428 | $79.07 | $271K | 349,964 |
| 2025-12-01 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +15,625 | 353,392 | ||
| 2025-08-05 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,739 | $51.74 | $556K | 337,767 |
| 2025-08-01 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +75,000 | 348,506 |
Page 1 of 2 · 39 trades